Role of TL1A in the pathogenesis of rheumatoid arthritis

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 5350-5357

  Zhang, Jun ^b,c,d   Wang, Xuehai ^a   Fahmi, Hassan ^a   Wojcik, Susan ^b   Fikes, James ^b   Yu, Youhua ^c   Wu, Jiangping ^a   Luo, Hongyu ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b GLAXOSMITHKLINE   (United States)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; FIBROBLAST; GERMINAL CENTER; HUMAN; HUMAN TISSUE; INFLAMMATION; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SPLEEN; SYNOVIAL FLUID; TH17 CELL;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; FIBROBLASTS; GERMINAL CENTER; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; JOINTS; MALE; MICE; MICE, INBRED DBA; RECOMBINANT PROTEINS; SPLEEN; SYNOVIAL FLUID; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76649096907     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802645     Document Type: Article

References (36)

1. Scrivo, R., M. Di Franco, A. Spadaro, and G. Valesini. 2007. The immunology of rheumatoid arthritis. Ann. NY Acad. Sci. 1108: 312-322.
2. Mauri, C., and M. R. Ehrenstein. 2007. Cells of the synovium in rheumatoid arthritis: B cells. Arthritis Res. Ther. 9: 205.
3. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
4. + Th cells that cause autoimmune arthritis. J. Exp. Med. 204: 41-47.
5. Lubberts, E., M. I. Koenders, and W. B. van den Berg. 2005. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7: 29-37.
6. Lundy, S. K., S. Sarkar, L. A. Tesmer, and D. A. Fox. 2007. Cells of the synovium in rheumatoid arthritis: T lymphocytes. Arthritis Res. Ther. 9: 202.
7. Stamp, L. K., M. J. James, and L. G. Cleland. 2004. Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol. Cell Biol. 82: 1-9.
8. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S. Hong, J. W. Perry, S. F. Chen, J. X. Zhou, et al. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492.
9. Jin, T., F. Guo, S. Kim, A. Howard, and Y. Z. Zhang. 2007. X-ray crystal structure of TNF ligand family member TL1A at 2.1A. Biochem. Biophys. Res. Commun. 364: 1-6.
10. Fang, L., B. Adkins, V. Deyev, and E. R. Podack. 2008. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205: 1037-1048.
11. Prehn, J. L., L. S. Thomas, C. J. Landers, Q. T. Yu, K. S. Michelsen, and S. R. Targan. 2007. The T cell costimulator TL1A is induced by FcγR signaling in human monocytes and dendritic cells. J. Immunol. 178: 4033-4038.
12. Cassatella, M. A., G. Pereira-da-Silva, I. Tinazzi, F. Facchetti, P. Scapini, F. Calzetti, N. Tamassia, P. Wei, B. Nardelli, V. Roschke, et al. 2007. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J. Immunol. 178: 7325-7333.
13. Bamias, G., C. Martin III, M. Marini, S. Hoang, M. Mishina, W. G. Ross, M. A. Sachedina, C. M. Friel, J. Mize, S. J. Bickston, et al. 2003. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171: 4868-4874. (Pubitemid 37310609)
14. Bai, C., B. Connolly, M. L. Metzker, C. A. Hilliard, X. Liu, V. Sandig, A. Soderman, S. M. Galloway, Q. Liu, C. P. Austin, and C. T. Caskey. 2000. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. USA 97: 1230-1235.
15. Pitti, R. M., S. A. Marsters, D. A. Lawrence, M. Roy, F. C. Kischkel, P. Dowd, A. Huang, C. J. Donahue, S. W. Sherwood, D. T. Baldwin, et al. 1998. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396: 699-703.
16. Zhang, J., T. W. Salcedo, X. Wan, S. Ullrich, B. Hu, T. Gregorio, P. Feng, S. Qi, H. Chen, Y. H. Cho, et al. 2001. Modulation of T-cell responses to alloantigens by TR6/DcR3. J. Clin. Invest. 107: 1459-1468. (Pubitemid 32522040)
17. Screaton, G. R., X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94: 4615-4619.
18. Warzocha, K., P. Ribeiro, C. Charlot, N. Renard, B. Coiffier, and G. Salles. 1998. A new death receptor 3 isoform: expression in human lymphoid cell lines and non-Hodgkin's lymphomas. Biochem. Biophys. Res. Commun. 242: 376-379.
19. Tan, K. B., J. Harrop, M. Reddy, P. Young, J. Terrett, J. Emery, G. Moore, and A. Truneh. 1997. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204: 35-46.
20. Pappu, B. P., A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al. 2008. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205: 1049-1062.
21. Bu, R., C. W. Borysenko, Y. Li, L. Cao, A. Sabokbar, and H. C. Blair. 2003. Expression and function of TNF-family proteins and receptors in human osteoblasts. Bone 33: 760-770.
22. Craxton, A., G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1998. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161: 3225-3236. (Pubitemid 128470613)
23. Al Lamki, R. S., J. Wang, A. M. Tolkovsky, J. A. Bradley, J. L. Griffin, S. Thiru, E. C. Wang, E. Bolton, W. Min, P. Moore, et al. 2008. TL1A both promotes and protects from renal inflammation and injury. J. Am. Soc. Nephrol. 19: 953-960.
24. Wang, E. C., A. Thern, A. Denzel, J. Kitson, S. N. Farrow, and M. J. Owen. 2001. DR3 regulates negative selection during thymocyte development. Mol. Cell. Biol. 21: 3451-3461.
25. Papadakis, K. A., J. L. Prehn, C. Landers, Q. Han, X. Luo, S. C. Cha, P. Wei, and S. R. Targan. 2004. TL1A synergizes with IL-12 and IL-18 to enhance IFN-γ production in human T cells and NK cells. J. Immunol. 172: 7002-7007.
26. Yang, C. R., S. L. Hsieh, F. M. Ho, and W. W. Lin. 2005. Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-κB-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression. J. Immunol. 174: 1647-1656.
27. Bendele, A. M., E. S. Chlipala, J. Scherrer, J. Frazier, G. Sennello, W. J. Rich, and C. K. Edwards III. 2000. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Arthritis Rheum. 43: 2648-2659.
28. Altman, R. D. 1987. Criteria for the classification of osteoarthritis of the knee and hip. Scand. J. Rheumatol. Suppl. 65: 31-39. (Pubitemid 17165512)
29. Fahmi, H., J. A. Di Battista, J. P. Pelletier, F. Mineau, P. Ranger, and J. Martel-Pelletier. 2001. Peroxisome proliferators-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum. 44: 595-607.
30. Bamias, G., S. I. Siakavellas, K. S. Stamatelopoulos, E. Chryssochoou, C. Papamichael, and P. P. Sfikakis. 2008. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin. Immunol. 129: 249-255.
31. Cho, Y. G., M. L. Cho, S. Y. Min, and H. Y. Kim. 2007. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun. Rev. 7: 65-70.
32. Chu, C. Q., M. Field, M. Feldmann, and R. N. Maini. 1991. Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34: 1125-1132.
33. Arend, W. P., and J. M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 38: 151-160.
34. Feldmann, M., F. M. Brennan, R. O. Williams, J. N. Woody, and R. N. Maini. 2004. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 18: 59-80.
35. Osawa, K., N. Takami, K. Shiozawa, A. Hashiramoto, and S. Shiozawa. 2004. Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis. Genes Immun. 5: 439-443.
36. Bull, M. J., A. S. Williams, Z. Mecklenburgh, C. J. Calder, J. P. Twohig, C. Elford, B. A. Evans, T. F. Rowley, T. J. Slebioda, V. Y. Taraban, et al. 2008. The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J. Exp. Med. 205: 2457-2464.